The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patient/oncologist decisions about adjuvant chemotherapy in ER+ve, HER2-ve early breast cancer following endopredict testing.
 
David J Bloomfield
No Relationships to Disclose
 
Amy Arbon
No Relationships to Disclose
 
Jane Cox
No Relationships to Disclose
 
Berkin Hack
No Relationships to Disclose
 
Julia Hall
No Relationships to Disclose
 
Catherine Harper-Wynne
No Relationships to Disclose
 
Sebastian Hinde
No Relationships to Disclose
 
Val Jenkins
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Sanofi/pH associates (Inst)
 
James Mackay
Consulting or Advisory Role - Myriad Genetics
Travel, Accommodations, Expenses - Myriad Genetics
 
Lucy A Matthews
No Relationships to Disclose
 
Shirley F May
No Relationships to Disclose
 
Adrian Moss
Consulting or Advisory Role - Myriad Genetics
 
Gargi Surendra Patel
Consulting or Advisory Role - Roche/Genentech
Speakers' Bureau - Roche/Genentech
 
Richard Simcock
No Relationships to Disclose
 
Eirini Thanopoulou
No Relationships to Disclose
 
Sarah Westwell
No Relationships to Disclose
 
Dominika Wlaszly
No Relationships to Disclose
 
Lesley Fallowfield
Honoraria - Amgen; Boehringer Ingelheim; Sanofi; TEVA
Consulting or Advisory Role - Amgen
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Sanofi/pH Associates (Inst)
Travel, Accommodations, Expenses - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Teva